NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 690116 | Null | 0.0123744972338278 | 0.38748877 |
NSC 693563 | Null | 0.0123744972338278 | 0.34082796 |
NSC 703318 | Null | 0.0123744972338278 | 0.29223788 |
NSC 709564 | Null | 0.0123744972338278 | 0.29312584 |
NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 0.0123744972338278 | 0.37763252 |
NSC 728040 | 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline | 0.0123744972338278 | 0.41000377 |
NSC 732698 | 1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne | 0.0123744972338278 | 0.46141558 |
NSC 736079 | 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine | 0.0123744972338278 | 0.49441635 |
NSC 736081 | 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine | 0.0123744972338278 | 0.39361649 |
NSC 736153 | Null | 0.0123744972338278 | 0.36978333 |